To some degree, this could explain the negative impact of DR5 on survival, but the TRAIL/DR5/NF‐κB or TRAIL/DR5/Rac1/PI3K/AKT pathway was still not enough to elucidate the malignant phenotype of tumor cells with high DR5 expression. This evidence concerns the gene RAC1 and neoplasm.